[go: up one dir, main page]

UA97235C2 - Quinazoline and fused pyrimidine derivatives as erbb inhibitors - Google Patents

Quinazoline and fused pyrimidine derivatives as erbb inhibitors

Info

Publication number
UA97235C2
UA97235C2 UAA200808026A UAA200808026A UA97235C2 UA 97235 C2 UA97235 C2 UA 97235C2 UA A200808026 A UAA200808026 A UA A200808026A UA A200808026 A UAA200808026 A UA A200808026A UA 97235 C2 UA97235 C2 UA 97235C2
Authority
UA
Ukraine
Prior art keywords
quinazoline
pyrimidine derivatives
fused pyrimidine
erbb inhibitors
inhibitors
Prior art date
Application number
UAA200808026A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джозеф П. ЛИССИКАТОС
Фредерик П. Мармсатер
Цян Чжао
Джули Мари ГРЕЩУК
Вейдонг Лиу
Девид Д. Хеннингс
Original Assignee
Аррей Байофарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аррей Байофарма Инк. filed Critical Аррей Байофарма Инк.
Priority claimed from PCT/US2006/044431 external-priority patent/WO2007059257A2/en
Publication of UA97235C2 publication Critical patent/UA97235C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

This invention provides compounds of Formula (I), wherein B, G, A, E R, R, R, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.I
UAA200808026A 2005-11-15 2006-11-15 Quinazoline and fused pyrimidine derivatives as erbb inhibitors UA97235C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73628905P 2005-11-15 2005-11-15
PCT/US2006/044431 WO2007059257A2 (en) 2005-11-15 2006-11-15 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

Publications (1)

Publication Number Publication Date
UA97235C2 true UA97235C2 (en) 2012-01-25

Family

ID=52286651

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200808026A UA97235C2 (en) 2005-11-15 2006-11-15 Quinazoline and fused pyrimidine derivatives as erbb inhibitors

Country Status (1)

Country Link
UA (1) UA97235C2 (en)

Similar Documents

Publication Publication Date Title
FR21C1031I1 (en)
GB2453058A (en) Kinase antagonists
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
ATE430747T1 (en) 2-PYRIMIDINYL-PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS
TW200720257A (en) Pyrimidine compounds and methods of use
MY167260A (en) Bi-aryl meta-pyrimidine inhibitors of kinases
CY1112142T1 (en) [D] Pyrimidines As Suspensions Of Akt Protein Kinase
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
WO2007061882A3 (en) Pyrrolotriazine kinase inhibitors
WO2006050109A3 (en) Novel kinase inhibitors
EP1675552A4 (en) PREPARATION OF 1,6-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS
TW200628452A (en) Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
TW200624426A (en) BACE inhibitors
UA85394C2 (en) Substituted quinolines as protein tyrosine kinase enzyme inhibitors
HK1120793A1 (en) 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
MXPA06010904A (en) Tricyclic pyrazole kinase inhibitors.
UA85505C2 (en) Kinase inhibitors
EP1773791A4 (en) Pyrrolotriazine compounds
UA97235C2 (en) Quinazoline and fused pyrimidine derivatives as erbb inhibitors